Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Pilot Study.

Trial Profile

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Pilot Study.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 May 2018

At a glance

  • Drugs Fluciclovine 18F (Primary)
  • Indications Cervical cancer; Endometrial cancer; Ovarian cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 10 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Aug 2019.
    • 10 May 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Aug 2019.
    • 10 May 2018 Planned initiation date changed from 1 Jan 2018 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top